Samia Joca

Aarhus University

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (17)

Bardia Varastehmoradi

Ferring Pharmaceuticals (Denmark)

DENMARK

View details

Jørgen Bo Hasselstrøm

Aarhus University

DENMARK

View details

Caroline Biojone

Aarhus University

DENMARK

View details

Gregers Wegener

Aarhus University

DENMARK

View details

Lívea Godoy

Aarhus University

DENMARK

View details

Caroline C Real

Aarhus University

DENMARK

View details

Kirstine Lykke Nielsen

Aarhus University

DENMARK

View details

Estéfano Pinilla

Aarhus University

DENMARK

View details

Anna Starnawska

Aarhus University

DENMARK

View details

Charlotte Uggerhøj Andersen

DENMARK

View details

Anne M Landau

Aarhus University

DENMARK

View details

Shokouh Arjmand

Aarhus University

DENMARK

View details

Ali H.Rafati

Translational Neuropsychiatry Unit, Department of Clinical Medicine, Aarhus University

DENMARK

View details

Luana Barreto Domingos

Aarhus University

DENMARK

View details

Simon Comerma-Steffensen

Aarhus University

DENMARK

View details

Heidi Kaastrup Müller

Associate Professor

Aarhus University

DENMARK

View details

Michaela Filiou

Max Planck Institute of Psychiatry

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Samia Joca

Research Interests

Contact this professor

Articles (19)

Modulation of the endocannabinoid system by (S)-ketamine in an animal model of depression

Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression.

New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect

Combined in vivo metabolic effects of quetiapine and methadone in brain and blood of rats

Approaches to embryonic neurodevelopment

Bradykinin actions in the central nervous system

Roles of cannabinoid CB1 and CB2 receptors in the modulation of psychostimulant responses

The antidepressant-like effect of doxycycline is associated with decreased nitric oxide metabolite levels in the prefrontal cortex

Sex and Estrous Cycle Are Not Mediators of S-Ketamine's Rapid-Antidepressant Behavioral Effects in a Genetic Rat Model of Depression

Decreased sensitivity to antidepressant drugs in Wistar Hannover rats submitted to two animal models of depression

Putative role of glial cells in treatment resistance depression

Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models

The Cannabis-Induced Epigenetic Regulation of Genes Associated with Major Depressive Disorder

Combined effects of quetiapine and opioids

The intersection of astrocytes and the endocannabinoid system in the lateral habenula

Tiny in size, big in impact

Fluoxetine acts concomitantly on dorsal and ventral hippocampus to Trk-dependently modulate the extinction of fear memory

Antipanic-like effect of esketamine and buprenorphine in rats exposed to acute hypoxia

Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum

Collaborators (17)

Bardia Varastehmoradi

Jørgen Bo Hasselstrøm

Caroline Biojone

Gregers Wegener

Lívea Godoy

Caroline C Real

Kirstine Lykke Nielsen

Estéfano Pinilla

Anna Starnawska

Charlotte Uggerhøj Andersen

Anne M Landau

Shokouh Arjmand

Ali H.Rafati

Luana Barreto Domingos

Simon Comerma-Steffensen

Heidi Kaastrup Müller

Michaela Filiou

Make your next move.